Back to results

RecruitingPhase 3

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

NCT07484217

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Clinical Research Site

Chino, California, United States

+12 additional locations

Contact

Study Director

2123325061 sol-mdd-302@axsome.com

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2026-02-23
Enrollment: 508 participants
Sponsor: Axsome Therapeutics, Inc.
Purpose: treatment

Locations (13)

Clinical Research SiteChino, California, United States
Clinical Research SiteRedlands, California, United States
Clinical Research SiteWalnut Creek, California, United States
Clinical Research SiteJacksonville, Florida, United States
Clinical Research SiteMiami, Florida, United States
Clinical Research SiteCherry Hill, New Jersey, United States
Clinical Research SiteToms River, New Jersey, United States
Clinical Research SiteBrooklyn, New York, United States
Clinical Research SiteThe Bronx, New York, United States
Clinical Research SiteCincinnati, Ohio, United States
Clinical Research SitePortland, Oregon, United States
Clinical Research SiteMemphis, Tennessee, United States
Clinical Research SiteDallas, Texas, United States